Jinxin Fertility Group Ltd
HKEX:1951
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.09
4.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jinxin Fertility Group Ltd
Jinxin Fertility Group Ltd
Total Equity
Jinxin Fertility Group Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jinxin Fertility Group Ltd
HKEX:1951
|
Total Equity
¥10.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Equity
¥7.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Total Equity
¥3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Equity
¥17.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Equity
¥7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
28%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Equity
¥7.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
36%
|
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.
See Also
What is Jinxin Fertility Group Ltd's Total Equity?
Total Equity
10.1B
CNY
Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Total Equity amounts to 10.1B CNY.
What is Jinxin Fertility Group Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
18%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Jinxin Fertility Group Ltd have been 11% over the past three years , 18% over the past five years .
You don't have any saved screeners yet
